Blueprint Medicines Competitors and Similar CompaniesClear all

Halozyme Therapeutics's competitors and similar companies include Deciphera Pharmaceuticals, Repare Therapeutics and AstraZeneca United States.
Halozyme Therapeutics
Halozyme Therapeutics
Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.
Repare Therapeutics
Repare Therapeutics
Repare Therapeutics is a company that develops oncology drugs for patients that target specific vulnerabilities of tumor cells.
AstraZeneca United States
AstraZeneca United States
AstraZeneca United States is a biopharmaceutical company.
Founding Date
Founding Date
1998
Founding Date
2003
Founding Date
2016
Founding Date
N/A
Type
Type
Public
Type
Public
Type
Public
Type
Subsidiary
Tags
Locations
Locations
San Diego, US HQ
Locations
Waltham, US HQ
Lawrence, US
Locations
Montréal, CA HQ
Cambridge, US
Locations
Wilmington, US HQ
Gaithersburg, US
Employees
Employees
373157% increase
Employees
35037% increase
Employees
179
Employees
N/A
Valuation ($)
Valuation ($)
6.4 b
Valuation ($)
2.2 b
Valuation ($)
152.4 m
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
$829.3m (FY, 2023)
Revenue (est.)
$163.4m (FY, 2023)
Revenue (est.)
$51.1m (FY, 2023)
Revenue (est.)
N/A
Cost of goods
Cost of goods
$192.4m (FY, 2023)
Cost of goods
$3.7m (FY, 2023)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
$636.9m (FY, 2023)
Gross profit
$159.6m (FY, 2023)
Gross profit
$51.1m (FY, 2023)
Gross profit
N/A
Net income
Net income
$281.6m (FY, 2023)
Net income
($194.9m) (FY, 2023)
Net income
($93.8m) (FY, 2023)
Net income
N/A

Operating

Patent Applications
Patent Applications
50 (FY, 2020)
Patent Applications
49 (Aug, 2017)
Patent Applications
N/A
Patent Applications
N/A
Patents (US)
Patents (US)
43 (FY, 2020)
Patents (US)
11 (Aug, 2017)
Patents (US)
N/A
Patents (US)
N/A

Funding

Total funding raised
Total funding raised
$ 171.9m
Total funding raised
$ 714m
Total funding raised
$ 150.5m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Deciphera Pharmaceuticals
HQ
Waltham, US
Employees
350↑ 37% increase

Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.

View company
Repare Therapeutics
HQ
Montréal, CA
Employees
179

Repare Therapeutics is a company that develops oncology drugs for patients that target specific vulnerabilities of tumor cells.

View company
AstraZeneca United States
HQ
Wilmington, US

AstraZeneca United States is a biopharmaceutical company.

View company